The Connecticut Department of Consumer Protection announced today that new preliminary data shows combined sales for adult-use cannabis and medical marijuana totaled more than $13.3 million for the period from Jan. 10, 2023, to Jan. 31, 2023.
The adult-use market recorded $5.1 million in sales during the month of January, while the medical marijuana market recorded $8.2 million in sales for the same period. Adult-use sales began on Jan. 10, 2023.
The data is available at ct.gov/cannabis.
The data does not include taxes collected at the point of sale on adult-use transactions, and is subject to further review by the department. Medical marijuana patients do not pay taxes on the purchase of their medicine.
Sales data for the medical marijuana market is not available prior to Jan. 10, 2023, as seed-to-sale tracking was not previously required for medical marijuana sales. Adult-use and medical marijuana sales are now recorded in BioTrack, the inventory tracking system used to monitor the movement of cannabis products in the state’s medical and adult-use cannabis markets.
Transaction limits of 1/4 ounce of raw flower or the equivalent remain in effect for all adult-use purchases. Medical marijuana patients may purchase up to 5 ounces per month and are not subject to individual transaction limits.
The Department of Consumer Protection is the regulatory agency for the adult-use cannabis industry. DCP does not make revenue projections, set sales expectations or regulate prices.
